2-氨基-4,5-二甲氧基苯甲醛主要作为医药中间体，用于相关药物的合成研究。
医药
合成路线 1（1. 合成：22608-87-3）
产率：99%
合成条件：With 5%-palladium/activated carbon; hydrogen In tetrahydrofuran at 20℃; for 0.25 h;
实验步骤：将Pd / C（5％，0.5g）悬浮在4,5-二甲氧基-2-硝基苯甲醛（3.1,1g，4.74mmol）的无水THF（10mL）溶液中，在室温下搅拌反应混合物 在50psi压力下在氢气氛中保持15分钟。 将反应混合物通过硅藻土过滤，并将滤液减压浓缩。 通过柱色谱法纯化残余物，得到标题化合物（0.85g，99％）。
参考文献：
- [1] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 8, p. 2480 - 2486 [2] European Journal of Medicinal Chemistry, 2017, vol. 127, p. 413 - 423 [3] Tetrahedron Letters, 2015, vol. 56, # 25, p. 3954 - 3960 [4] Patent: JP2018/52878, 2018, A. Location in patent: Paragraph 0149 [5] Canadian Journal of Chemistry, 2004, vol. 82, # 3, p. 461 - 478 [6] Heteroatom Chemistry, 2008, vol. 19, # 3, p. 229 - 233 [7] Tetrahedron, 2001, vol. 57, # 15, p. 3087 - 3098 [8] Organic Letters, 2010, vol. 12, # 23, p. 5502 - 5505 [9] Chemische Berichte, 1943, vol. 76, p. 1011,1015 [10] Journal of the American Chemical Society, 1935, vol. 57, p. 1329 [11] Zhurnal Obshchei Khimii, 1941, vol. 11, p. 647 [12] Chem.Abstr., 1941, p. 5869,6937 [13] Journal of Heterocyclic Chemistry, 1980, vol. 17, # 7, p. 1489 - 1495 [14] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 3, p. 641 - 647 [15] Journal of Heterocyclic Chemistry, 2006, vol. 43, # 3, p. 623 - 628 [16] Heterocycles, 2005, vol. 65, # 9, p. 2095 - 2105 [17] Tetrahedron, 2004, vol. 60, # 13, p. 2937 - 2942 [18] Helvetica Chimica Acta, 1922, vol. 5, p. 548 [19] Organic Letters, 2008, vol. 10, # 2, p. 173 - 175 [20] Organic Letters, 2010, vol. 12, # 12, p. 2841 - 2843 [21] Chemical Communications, 2010, vol. 46, # 29, p. 5244 - 5246 [22] ACS Combinatorial Science, 2012, vol. 14, # 5, p. 316 - 322 [23] Patent: US2012/184548, 2012, A1. Location in patent: Page/Page column 18 [24] Synthetic Communications, 2014, vol. 44, # 3, p. 346 - 351
